My NCBISign In
Recent advances in systemic therapy: Advances in systemic therapy for HER2-positive metastatic breast cancer
Phuong Khanh H Morrow, Francisco Zambrana, Francisco J Esteva
Breast Cancer Res. 2009; 11(4): 207. Published online 2009 July 15. doi: 10.1186/bcr2324
PMCID:
PMC2750101
Abstract Full Text PDF–538K

Is Cited by the Following 3 Articles in this Archive:

Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer
Andrea Camerini, Sara Donati, Paolo Viacava, Olimpia Siclari, Cheti Puccetti, Gianna Tartarelli, Chiara Valsuani, Filomena De Luca, Leonardo Martini, Andrea Cavazzana, Domenico Amoroso
J Exp Clin Cancer Res. 2011; 30(1): 38. Published online 2011 April 11. doi: 10.1186/1756-9966-30-38
PMCID:
PMC3080331
Abstract Full Text PDF–2.1M
Biologic and Immunologic Effects of Preoperative Trastuzumab for Ductal Carcinoma in Situ of the Breast
Henry M. Kuerer, Aman U. Buzdar, Elizabeth A. Mittendorf, Francisco J. Esteva, Anthony Lucci, Luis M. Vence, Laszlo Radvanyi, Funda Meric-Bernstam, Kelly K. Hunt, W. Fraser Symmans
Cancer. Author manuscript; available in PMC 2012 January 1.
Published in final edited form as: Cancer. 2011 January 1; 117(1): 39–47. Published online 2010 August 24. doi: 10.1002/cncr.25399
PMCID:
PMC2997136
Abstract Full Text PDF–406K
Recent advances in systemic therapy for breast cancer: new technologies for a new era
Paul Ellis
Breast Cancer Res. 2009; 11(4): 107. Published online 2009 August 28. doi: 10.1186/bcr2254
PMCID:
PMC2750100
Full Text PDF–38K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk